Pulmonary Hypertension

The Significance of Databases for PAH - MD Magazine The Significance of Databases for PAH - MD Magazine Validating REVEAL: Can Scores Accurately Predict Survival in SSc-PAH? - Rheumatology Advisor Owlstone, Actelion Team to Develop Breath-based Test for Diagnosing PH - Pulmonary Hypertension News The Significance of Databases for PAH - MD Magazine Posted: 30 May 2019 05:30 AM PDT Patients who present with symptoms of pulmonary arterial hypertension could land on any spot of a spectrum which indicates minimal to significant risk of comorbidities, and even mortality. The uncommon, burdensome condition often requires that patients are receiving optimized therapy early and aggressively following diagnosis. That puts pressure on investigators to broaden their access to clinical data. In an interview with MD Magazine® , Rich Channick, MD, director of the Acute and Thromboembolic Disease Program at the UCLA Medical Center, and P...

The major sign in your breath that could mean you have high blood pressure - Express The major sign in your breath that could mean you have high blood pressure - Express Posted: 29 May 2019 10:34 AM PDT Pulmonary hypertension is a rare condition that can affect people of all ages, but it's more common in people who have another heart or lung condition. High  blood pressure , otherwise known as pulmonary hypertension, involves the loop of vessels connecting the heart and lungs. Your breathing is therefore affected by high blood pressure and if you are noticing that you are catching your breath after mild activity it could be a danger sign. Having a shortness of breath after mild exercising could be a symtom of high blood pressure.  Doctor Valerie McLaughlin, director of pulmonary hypertension program at the University of Michigan Frankel cardiovascular centre said: "This shortness of breath occurs because the right side of the he...

Ultrasound-Based Denervation Gains Traction in PAH - MedPage Today Ultrasound-Based Denervation Gains Traction in PAH - MedPage Today Posted: 23 May 2019 02:00 PM PDT PARIS -- Ultrasound-based denervation helped patients with pulmonary arterial hypertension (PAH) when medical therapy was not enough, the TROPHY1 study indicated. Improvements in pulmonary hemodynamics were observed 4-6 months among the 23 patients who underwent pulmonary artery denervation with SoniVie's TIVUS therapeutic intravascular ultrasound system: Pulmonary artery pressure reduced (looking at minimum, maximum, and median values) Pulmonary vascular resistance down from ~675 to ~575 dyn·sec/cm 5 Right atrial pressure down from ~10.5 to ~8.0 mm Hg Pulmonary arterial compliance increased from ~1.6 to ~1.9 mL/mm Hg As late as 8 months, patients improved 6-minute walk distances by around 40m and daily step counts by approximately 800 steps, Alex Rothman, BM...

The Significance of Databases for PAH - MD Magazine The Significance of Databases for PAH - MD Magazine Owlstone, Actelion Team to Develop Breath-based Test for Diagnosing PH - Pulmonary Hypertension News Validating REVEAL: Can Scores Accurately Predict Survival in SSc-PAH? - Rheumatology Advisor Bayer US Launches $1M Grant Program to Boost PH Clinical Research - Pulmonary Hypertension News The Significance of Databases for PAH - MD Magazine Posted: 30 May 2019 05:30 AM PDT Patients who present with symptoms of pulmonary arterial hypertension could land on any spot of a spectrum which indicates minimal to significant risk of comorbidities, and even mortality. The uncommon, burdensome condition often requires that patients are receiving optimized therapy early and aggressively following diagnosis. That puts pressure on investigators to broaden their access to clinical data. In an interview with MD Magazine® , Rich Ch...

The Significance of Databases for PAH - MD Magazine The Significance of Databases for PAH - MD Magazine Posted: 30 May 2019 05:30 AM PDT Patients who present with symptoms of pulmonary arterial hypertension could land on any spot of a spectrum which indicates minimal to significant risk of comorbidities, and even mortality. The uncommon, burdensome condition often requires that patients are receiving optimized therapy early and aggressively following diagnosis. That puts pressure on investigators to broaden their access to clinical data. In an interview with MD Magazine® , Rich Channick, MD, director of the Acute and Thromboembolic Disease Program at the UCLA Medical Center, and Prof. Sean Gaine, director of the National Pulmonary Hypertension Unit in Ireland, explained the utility of national, international registries of PAH patients, and how it influences their ability to identify low- and high-risk patients. [embedded content] MD Mag: How ...

The Significance of Databases for PAH - MD Magazine The Significance of Databases for PAH - MD Magazine Posted: 30 May 2019 05:30 AM PDT Patients who present with symptoms of pulmonary arterial hypertension could land on any spot of a spectrum which indicates minimal to significant risk of comorbidities, and even mortality. The uncommon, burdensome condition often requires that patients are receiving optimized therapy early and aggressively following diagnosis. That puts pressure on investigators to broaden their access to clinical data. In an interview with MD Magazine® , Rich Channick, MD, director of the Acute and Thromboembolic Disease Program at the UCLA Medical Center, and Prof. Sean Gaine, director of the National Pulmonary Hypertension Unit in Ireland, explained the utility of national, international registries of PAH patients, and how it influences their ability to identify low- and high-risk patients. [embedded content] MD Mag: How ...

The Significance of Databases for PAH - MD Magazine The Significance of Databases for PAH - MD Magazine Posted: 30 May 2019 05:30 AM PDT Patients who present with symptoms of pulmonary arterial hypertension could land on any spot of a spectrum which indicates minimal to significant risk of comorbidities, and even mortality. The uncommon, burdensome condition often requires that patients are receiving optimized therapy early and aggressively following diagnosis. That puts pressure on investigators to broaden their access to clinical data. In an interview with MD Magazine® , Rich Channick, MD, director of the Acute and Thromboembolic Disease Program at the UCLA Medical Center, and Prof. Sean Gaine, director of the National Pulmonary Hypertension Unit in Ireland, explained the utility of national, international registries of PAH patients, and how it influences their ability to identify low- and high-risk patients. [embedded content] MD Mag: How ...